off brand semaglutide Buyer beware: Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for consumers FDA reports adverse effects of

Sourcing any medicine from unregulated suppliers significantly increases the risk of getting a product which is either falsified or not approved for use

Ann Brown says the older she gets, the more difficult it is to keep the weight off

Kennedy C, Ali O, Farnan R, Hall M, Stinson J, O'Connor P, et al

Nat Rev Dis Primers

Those included: Nausea (about 29 to 42 percent of participants, depending on the dose) Diarrhea (25 to 34 percent) Constipation (24 to 26 percent) Vomiting (11 to 25 percent) Upper respiratory tract infection (12 to 14 percent) Interestingly, more people taking a placebo dropped out of the trial because of side effects than participants taking the lowest dose of retatrutide (4.9 percent compared with 4.1 percent)

There are other nuances as well